Arlington Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEZ
SCM
RCM
1CP
KIM
CA
Arlington Partners's BMEZ Position: Q1 2023 in Review
Arlington Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2023, closing a stake of 2,971 shares — an estimated $45.8K sold.
Arlington Partners first reported a position in BMEZ in Q4 2022 and held it in 1 quarter. The position peaked at $45.8K in Q4 2022. 85 funds tracked by Wall St. Rank hold BMEZ as of Q1 2023.
- Arlington Partners reported no remaining BlackRock Health Sciences Trust II position as of Q1 2023 after selling out during the quarter.
- Arlington Partners sold 2,971 BlackRock Health Sciences Trust II shares in Q1 2023, an estimated $45.8K.
- Arlington Partners first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and held it in 1 quarter.
- Arlington Partners's BlackRock Health Sciences Trust II position peaked at $45.8K in Q4 2022.
- 85 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2023.
Based on Arlington Partners's 13F filing for Q1 2023, filed 26 Apr 2023.